Atlas Trials

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Clinical trial NCT04236960 · COMPLETED

Trial details

NCT number
NCT04236960
Sponsor
Walvax Biotechnology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Meningococcal Infections
Start date
2018-07-17
Primary completion
2019-09-16
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.